Welcome to our dedicated page for Duke Robotics SEC filings (Ticker: DUKRD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Duke Robotics's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Duke Robotics's regulatory disclosures and financial reporting.
Duke Robotics Corp. has updated its 2021 Equity Incentive Plan to clarify that a total of 480,000 shares of common stock are issuable under the plan. The share pool was previously increased by the board of directors from 192,000 to 360,000 shares and then to 480,000 shares, with the latest change approved on March 10, 2026.
DUKE Robotics Corp. director Antebi Eran received an option grant for 4,000 shares of common stock at an exercise price of $7.88 per share. The option was fully unheld before this award, so his post-transaction derivative holdings in this grant are 4,000 options. The option vests in three equal annual installments beginning on March 10, 2027, and expires on March 10, 2032. This is a compensation-related award, not an open-market trade.
Zakai Shlomo reported acquisition or exercise transactions in this Form 4 filing.
DUKE Robotics Corp. chief financial officer Zakai Shlomo received a grant of options to purchase 10,000 shares of common stock, exercisable at $7.88 per share. The option expires on March 10, 2032 and vests in three equal annual installments beginning on March 10, 2027.
DUKE Robotics Corp. director Golan Keren Gousman received an option grant for 4,000 shares of common stock at an exercise price of $7.88 per share, expiring on March 10, 2032. The option vests in three equal annual installments beginning on March 10, 2027.
DUKE Robotics Corp. reported that Chief Technology Officer Maor Vadim received a grant of options to purchase 4,000 shares of common stock at an exercise price of $7.88 per share. These options are a form of equity compensation rather than an open‑market trade.
The options expire on March 10, 2032 and vest in three equal annual installments beginning on March 10, 2027. After this award, Vadim holds options for 4,000 underlying shares directly, with no sales or exercises reported in this filing.
DUKE Robotics Corp. chief executive officer Balucka Yossef received a grant of options to purchase 16,000 shares of common stock at an exercise price of $7.88 per share. The options vest in three equal annual installments beginning on March 10, 2027 and expire on March 10, 2032. Following the grant, he holds 16,000 options directly.
DUKE Robotics Corp. director Nachtomy Erez received an option grant covering 16,000 shares of common stock at an exercise price of $7.88 per share. The option vests in three equal annual installments beginning on March 10, 2027, and expires on March 10, 2032. Following this grant, Erez holds options on 16,000 shares directly.
DUKE Robotics Corp. files its annual report describing a robotics business focused on stabilized weapon systems and civilian drone-based infrastructure maintenance, including its IC Drone insulator-cleaning platform and new AEROTRACE™ monitoring solution. The company relies on collaborations such as its Elbit Systems “Bird of Prey” defense partnership and commercial agreements with Israel Electric Corporation.
DUKE highlights significant capital structure activity, including private placements, warrant amendments, an authorized share increase to 350,000,000 common shares, a 25‑for‑1 reverse stock split and expansions of its 2021 Equity Incentive Plan. The report discloses that current cash is not sufficient for 12 months of operations, raising substantial doubt about its ability to continue as a going concern and emphasizing the need for additional financing.
The filing also outlines heavy dependence on government and quasi‑government customers, extensive regulatory exposure in Israel, the U.S. and Europe, and geopolitical risks tied to operations in Israel. As of March 11, 2026, DUKE had 2,252,151 common shares outstanding and a non‑affiliate equity market value of $4,120,827 as of its most recent second fiscal quarter.